Ms Shamara Monique Long, LVN | |
760 W. Mountain View St., Alta Dena, CA 91001 | |
(626) 798-6793 | |
Not Available |
Full Name | Ms Shamara Monique Long |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 760 W. Mountain View St., Alta Dena, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407031453 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | VN 230989 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Shamara Monique Long, LVN 760 W. Mountain View St., Alta Dena, CA 91001 Ph: (517) 879-3209 | Ms Shamara Monique Long, LVN 760 W. Mountain View St., Alta Dena, CA 91001 Ph: (626) 798-6793 |
News Archive
In France, more than 860,000 people suffer from Alzheimer's disease and related disorders, making them the largest cause of age-related loss of intellectual function. Cognitive impairments observed in Alzheimer's disease result from the accumulation of abnormal tau proteins in nerve cells undergoing degeneration . We know that obesity, a major risk factor in the development of insulin resistance and type 2 diabetes, increases the risk of dementia during the aging process.
The health care system in the U.S. is a $2.5 trillion industry and depends heavily on communication and the transfer of information via the Internet. This puts it at ever-increasing risk of a cyberterrorism attack, which could jeopardize lives and threaten patient care and privacy. Cyber threats are on the rise, and U.S. health care organizations must be better prepared to deal with them, according to an article published in Telemedicine and e-Health, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
To some, the California Nurses Association's political tactics in pushing for a single-payer health system seemed a bit, well, extreme.
Practicing gratitude and looking to the future will help safeguard our mental wellbeing during future Covid-19 lockdowns, a new study in the Journal of Positive Psychology reports.
Amgen today announced the U.S. Food and Drug Administration has invited the Company to participate in a meeting of the Oncologic Drugs Advisory Committee (ODAC) on Feb. 8, 2012 to discuss the supplemental Biologics License Application (sBLA) for XGEVA (denosumab) to treat men with castration-resistant prostate cancer (CRPC) at high risk of developing bone metastases.
› Verified 8 days ago